Genotype Based Personalized Prescription of Nevirapine

Clinical trial NCT00986063 · COMPLETED

Trial details

NCT number: NCT00986063
Sponsor: Surakameth Mahasirimongkol
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Nevirapine Induced Rash Nevirapine Induced Hepatitis HIV Adverse Side Effects AIDS HIV Infections

Start date: 2009-07-01
Primary completion: 2012-07-01
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.